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Patients with cirrhosis admitted to an Intensive Care Unit
Letters to the EditorTo the Editor,
We read with great interest the study by Levesque et al. [1],
recently published in the Journal of Hepatology, regarding the
prognostic ability of ICU-speciﬁc scores, such as SOFA score,
and liver-speciﬁc scores [Child-Pugh (CTP), standard MELD, and
MELD-serum sodium scores] in 377 patients with cirrhosis
admitted to their intensive care unit (ICU). As the authors men-
tioned, their study are in accordance with our systematic review
[2] that general ICU prognostic models are superior to the CTP
score in cirrhotics with acute deterioration of chronic liver dis-
ease, and they conﬁrmed our previous study [3], which showed
that the SOFA score had better discriminative accuracy for mor-
tality, compared to the MELD score.
To add to their evaluation, we report our experience in 412
patients with cirrhosis who were consecutively admitted to
ICU. At admission, several variables, including demographic and
clinical data, as well as laboratory parameters had been prospec-
tively collected for each patient. During the ICU stay, gastrointes-
tinal bleeding episodes, development of aspiration pneumonia
and additional use of inotropes, mechanical ventilation or
haemoﬁltration were also recorded. Univariate comparisons and
then multivariate analysis of variables at baseline were per-
formed to identify independent factors associated with mortality.
Liver-speciﬁc prognostic models [CTP, standard MELD,
MELD-sodium (MELD-Na, iMELD, and MESO) scores], as well as
general ICU models (APACHE II and SOFA scores) were evaluated
on ICU admission. In addition, we evaluated for the ﬁrst time the
performance of the re-weighted MELD. The discriminative ability
of the prognostic models to predict the outcome of patients was
evaluated by using AUC, while sensitivity, speciﬁcity, positive
(PPV), and negative (NPV) predictive values were calculated.
The overall mortality in ICU or in hospital was 61.2% and 187
(45.4%) patients died due to multiple organ failure. Arterial
lactate was independently associated with mortality (OR: 1.23,
p = 0.001). The cirrhotics who died, compared to those who
survived, had signiﬁcantly higher median values of CTP (12 vs.
10), APACHE II (21 vs. 16), MELD (28 vs. 18) MELD-sodium
(MELD-Na: 32 vs. 23, iMELD: 47 vs. 37, and MESO: 2.1 vs. 1.4)
scores, re-weighted MELD (5.4 vs. 4.1), and SOFA (12 vs. 9)
scores (p <0.001) at admission. Table 1 shows the discriminativeTable 1. Prediction of mortality in 412 cirrhotics admitted to intensive care unit.
Prognostic score Area under the 
ROC curve 
(AUC)
Cut-off point Mortality at th
Child-Pugh 0.67 10 <10: 37%, ≥1
MELD 0.80 21 <21: 31%, ≥2
MELD-Na 0.75 25 <25: 52%, ≥2
iMELD 0.76 43 <43: 45%, ≥4
MESO 0.78 1.5 <1.5: 32%, ≥1
Re-weighted MELD 0.79 4.3 <4.3: 32%, ≥4
SOFA 0.85 10 <10: 27%, ≥1
APACHE II 0.74 19 <19: 42%, ≥1
PPV, positive predictive value; NPV, negative predictive value.
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the best cut-off point in our cohort. Similar to the study by
Levesque et al. [1], we found that the SOFA score had the best
discriminative accuracy for outcome (AUC = 0.85), followed by
the standard MELD score (AUC = 0.80), but their difference was
not signiﬁcant (p = 0.27). In addition, we found no difference
between the standard MELD and the different models
incorporating serum sodium (MELD-Na, iMELD, and MESO)
(AUC: 0.75, 0.76, and 0.78, respectively, p >0.05 for all
comparisons), while the re-weighted MELD had also similar
performance (AUC: 0.79, p >0.05). SOFA score had the highest
speciﬁcity, but, in contrast to Levesque et al. [1], the NPV was
relatively low in all prognostic scores.
Thus, deterioration of liver function is not the main determi-
nant of outcome in cirrhotics admitted to ICU [2], which is impor-
tant, as improvement in multi-organ support, and not just liver
support, such as MARS, is needed to improve outcome. In fact,
the severity of organ dysfunction changes over time, either due
to progressive illness or therapeutic intervention, and therefore,
a prognostic system measured at subsequent time points may
be more accurate, compared to baseline. Indeed, we showed this
for the ﬁrst time, in that the SOFA score performed better at 48 h,
compared to that calculated at admission [4]. This requires fur-
ther validation, but does conﬁrm that the SOFA score in general
is a valid clinical tool for clinical decision-making. Finally, Lev-
esque et al. [1] did not evaluate arterial lactate, but in our cohort,
it was an independent factor related to mortality. We believe that
lactate should be incorporated as a tool for evaluation of treat-
ment response. Arterial lactate reﬂects multiple organ dysfunc-
tion and serial measurements of lactate (at admission and after
48 h) have been associated with the adverse outcomes in patients
with acute complications of cirrhosis [4].e 
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We thank Dr. Cholongitas and colleagues for their comments
on our paper on the prognostic score for cirrhotic patients admit-
ted to an Intensive Care Unit (ICU) and for sharing their
experience.
Consistent with previous studies in critical care, these two
large series (our study with 377 patients and the evaluation of
Cholongitas et al. with 412 patients) showed that the prognosis
of patients with cirrhosis admitted to the ICU is more determined
by the number of organ failure (SOFA score) then by the deterio-
ration of the liver function.
In a critical situation, hyperlactatemia is mainly associated
with respiratory and cardiovascular dysfunction, both of which
may lead to systemic tissue hypoxia. In cirrhotic patients
admitted to the ICU, hyperlactatemia may reﬂect both an
increased production (overproduction due to systemic tissue
hypoxia associated with multiorgan failure) and a decreased
hepatic clearance (due to hepatic dysfunction). In our cohort, we
did not evaluate this marker because it is not included in the dif-
ferent prognostics scores studied in our paper (SAPS II, SOFA,
MELD. . .). Cholongitas et al. suggest that arterial lactate may be
a prognostic marker in patients with cirrhosis admitted to ICU.
Although, there is a lack of information in the data provided by
Cholongitas et al., it may be interesting to know whether a signif-
icant correlation between arterial lactate and SOFA score, the
presence of sepsis or the number of organ dysfunction exists. Even
though these associations dot not necessarily imply causality,they do suggest that multiple organ failure could be involved in
the development of hyperlactatemia.
With the SOFA score at admission, the severity of organ
dysfunction assessment and their change over time, the liver
function, the primary ICU diagnosis (sepsis or systemic inﬂam-
mation), and a possible candidacy for liver transplantation, the
arterial lactate may be an additional tool for the decision-making
process in the management of cirrhotic patients admitted to ICU.
But, to identify, in emergency at ICU admission, patients who
might beneﬁt from an ICU transfer and from an aggressive treat-
ment is still complex and challenging. We agree with Cholongitas
et al. that all cirrhotic patients admitted to ICU require re-assess-
ment in the days following the admission. For some cirrhotic
patients, the ICU treatment is futile and generates a signiﬁcant
cost. Consequently, as we concluded in our study, criteria consist-
ing of a combination of factors such SOFA and MELD scores,
together with the development of sepsis and/or the need for
organ support, might result in an improved predictive power over
each component alone and will provide guidance to the optimal
management of cirrhotic patients admitted to the ICU.
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